Figure 4. a, Wild type (hsf-1+/+) and b, HSF-1 null (hsf-1−/−) (MEFs) were treated for 4 h with probe ML346 (compound F1) at the indicated concentrations.

Figure 4

a, Wild type (hsf-1+/+) and b, HSF-1 null (hsf-1−/−) (MEFs) were treated for 4 h with probe ML346 (compound F1) at the indicated concentrations. Relative levels of multiple cytoprotective genes were measured by real-time PCR (qPCR). See [9] for details.

From: ML346: A Novel Modulator of Proteostasis for Protein Conformational Diseases

Cover of Probe Reports from the NIH Molecular Libraries Program
Probe Reports from the NIH Molecular Libraries Program [Internet].

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.